HSA
NBP

HBK Sorce Advisory’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

HBK Sorce Advisory’s Portfolio NBP Stock Details NBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-46,060
Closed -$37.9K – 607
2025
Q1 		$37.9K Buy
+46,060
New +$43.7K ﹤0.01% 574

Other funds holding NBP

HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
ACM
Ariose Capital Management Central, Hong Kong, Hong Kong $234M AUM 640.82% 1-Year Est. Return
AIMCA
Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $16.7B AUM 23.27% 1-Year Est. Return

HBK Sorce Advisory's NBP Position: Q2 2025 in Review

HBK Sorce Advisory sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q2 2025, closing a stake of 46,060 shares — an estimated $37.9K sold.

HBK Sorce Advisory first reported a position in NBP in Q1 2025 and held it in 1 quarter. The position peaked at $37.9K in Q1 2025. 32 funds tracked by Wall St. Rank hold NBP as of Q2 2025.

  • HBK Sorce Advisory reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q2 2025 after selling out during the quarter.
  • HBK Sorce Advisory sold 46,060 NovaBridge Biosciences American Depositary Shares shares in Q2 2025, an estimated $37.9K.
  • HBK Sorce Advisory first reported a position in NovaBridge Biosciences American Depositary Shares in Q1 2025 and held it in 1 quarter.
  • HBK Sorce Advisory's NovaBridge Biosciences American Depositary Shares position peaked at $37.9K in Q1 2025.
  • 32 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q2 2025.

Based on HBK Sorce Advisory's 13F filing for Q2 2025, filed 4 Aug 2025.